https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Modelling cost-effectiveness of high-dose chemotherapy as treatment for relapsed aggressive non-Hodgkin lymphoma in an Australian setting https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8234 Sat 24 Mar 2018 10:47:29 AEDT ]]> Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20121 Sat 24 Mar 2018 07:51:45 AEDT ]]> Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): A report from The Center For International Blood & Marrow Transplant Research (CIBMTR) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5007 Sat 24 Mar 2018 07:44:14 AEDT ]]> A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18630 Mon 20 Jul 2015 16:38:11 AEST ]]>